E3330
CAS: 136164-66-4
Ref. 3D-LFA16466
5mg | Ausgelaufen | ||
10mg | Ausgelaufen | ||
25mg | Ausgelaufen | ||
50mg | Ausgelaufen | ||
100mg | Ausgelaufen |
Produktinformation
- Undecanoic acid, 2-[(4,5-dimethoxy-2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)methylene]-, (E)-
- (2E)-2-[(4,5-Dimethoxy-2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)methylene]undecanoic acid
- Undecanoic acid, 2-[(4,5-dimethoxy-2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)methylene]-, (2E)-
- E 3330
- APX 3330
E3330 is a drug that has been shown to have anti-tumor activity in experimental models. It inhibits the expression of genes regulated by DNA binding and transcriptional regulation. E3330 also has anti-inflammatory properties, which may be due to its ability to inhibit toll-like receptor 4 (TLR4). E3330 has been shown to reduce tumor size in vivo and may be an effective treatment for bowel disease, colorectal cancer, and other types of cancer.